Delivery Order SPE2DB20D7059-SPE2DB24FPYU2
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GLATIRAMER 40 MG/ML SYRINGE medications. The contract has a completion date of February 16, 2024 and a potential value of $2,832.12. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering the pharmaceutical products to DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565214640 GLATIRAMER 40 MG/ML SYRINGEML. The contract has a ceiling value of $2,832.12 and a completion date of July 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to procure a comprehensive range of pharmaceutical and medical supplies from...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,030.03 firm fixed price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product, to support the requirements of the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564082002 - GLATIRAMER 40 MG/ML SYRINGEML. The award, valued at $2,937.92, has a period of performance through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Glatiramer 40 mg/ml syringes. The $1,129.45 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of January 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,664.24 firm fixed-price delivery order is for the supply of 4559656211 GLATIRAMER 40 MG/ML syringes, with a completion date of January 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,088.20 firm fixed-price delivery order contract is for the supply of GLATIRAMER 40 MG/ML SYRINGE medication, with a period of performance through July 11, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Glatiramer 40 mg/mL syringe. The award has a ceiling value of $2,832.12 and an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,687.43 Firm Fixed Price delivery order is for the supply of Glatiramer 40 mg/mL syringes, with a completion date of March 4, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FPYU2Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The award is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product, with a potential value of $2,832.12 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense, through multiple indefinite delivery contracts (IDCs) with DLA. This includes a single award IDC with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/8/24 |